Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 3/2012

Open Access 01-03-2012 | Head and Neck

Are all prognostic factors in parotid gland carcinoma well recognized?

Authors: Dominik Stodulski, Boguslaw Mikaszewski, Czeslaw Stankiewicz

Published in: European Archives of Oto-Rhino-Laryngology | Issue 3/2012

Login to get access

Abstract

The aim of his study was to assess the treatment results and prognostic factors in patients with parotid gland carcinoma. The material consisted of 109 patients treated surgically, with or without complementary radiotherapy, between 1978 and 2008 (follow-up at least 5-years). 5-year overall and disease-specific survival were observed in 57.0% of the patients and 5-year disease-free survival was achieved in 50.0%. Univariate analysis including ten clinical and pathological features to assess their prognostic value was done. Parapharyngeal space invasion, facial nerve palsy, and high grade of tumor malignancy were the factors with the highest influence on the treatment results, because their presence decreased the chance for recovery 9.8, 9.7, and 8.2 times, respectively. Histologically positive cervical lymph nodes and extraparenchymal extension were the other factors connected with poor prognosis (prognosis worse 6.7 and 5.4 times, respectively). Clinically positive cervical lymph nodes, positive/uncertain microscopic margin, involvement of the deep lobe, or the whole gland increased the risk of treatment failure 3.4, 3.1, and 2.8, respectively. The age ≥60 years and male gender were statistically significant factors, correlated with poor prognosis and decreased chance for recovery 2.4 and 2.6 times. T-status and clinical stage had important influence on 5-year disease-free survival rate because there were significant differences in the treatment results between individual stages. Multivariate analysis proved that the independent prognostic value, among anatomic structures involved by the neoplasm, had mandible, facial nerve, and skin infiltration. Among tumor-related factors, T-stage and grade had the statistically significant influence on treatment results, and stage and lymph nodes metastases among clinical and pathological features. These results confirm the value of actually used TNM classification (2002). Although the parapharyngeal space invasion is a factor, which seems to have a significant, poor prognostic value, it was not included in this classification.
Literature
1.
go back to reference Eneroth CM (1971) Salivary gland tumors in the parotid gland, submandibular gland, and the palate region. Cancer 27:1415–1418PubMedCrossRef Eneroth CM (1971) Salivary gland tumors in the parotid gland, submandibular gland, and the palate region. Cancer 27:1415–1418PubMedCrossRef
2.
go back to reference Eveson JW, Cawson RA (1985) Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol 146:51–58PubMedCrossRef Eveson JW, Cawson RA (1985) Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol 146:51–58PubMedCrossRef
3.
go back to reference Carinci F, Farina A, Pelucchi S, Calearo C, Fini-Storchi O, Merlo R, Pastore A (2001) Parotid gland carcinoma: 1987 and 1997 UICC T classifications compared for prognostic accuracy at 5 years. Eur Arch Otorhinolaryngol 258:150–154PubMedCrossRef Carinci F, Farina A, Pelucchi S, Calearo C, Fini-Storchi O, Merlo R, Pastore A (2001) Parotid gland carcinoma: 1987 and 1997 UICC T classifications compared for prognostic accuracy at 5 years. Eur Arch Otorhinolaryngol 258:150–154PubMedCrossRef
4.
go back to reference Numata T, Muto H, Shiba K, Nagata H, Terada N, Konno A (2000) Evaluation of the validity of the 1997 International Union against cancer TNM classification of major salivary gland carcinoma. Cancer 89:1664–1669PubMedCrossRef Numata T, Muto H, Shiba K, Nagata H, Terada N, Konno A (2000) Evaluation of the validity of the 1997 International Union against cancer TNM classification of major salivary gland carcinoma. Cancer 89:1664–1669PubMedCrossRef
5.
go back to reference Sobin LH, Wittekind C (eds) (2002) Salivary glands. UICC TNM classification of malignant tumours, 6th edn. Wiley, New York, pp 48–51 Sobin LH, Wittekind C (eds) (2002) Salivary glands. UICC TNM classification of malignant tumours, 6th edn. Wiley, New York, pp 48–51
6.
go back to reference Godballe C, Schultz JH, Krogdahl A, Møller-Grøntved A, Johansen J (2003) Parotid carcinoma: impact of clinical factors on prognosis in a histologically revised series. Laryngoscope 113:1411–1417PubMedCrossRef Godballe C, Schultz JH, Krogdahl A, Møller-Grøntved A, Johansen J (2003) Parotid carcinoma: impact of clinical factors on prognosis in a histologically revised series. Laryngoscope 113:1411–1417PubMedCrossRef
7.
go back to reference Leverstein H, van der Wal JE, Tiwari RM, Tobi H, van der Waal I, Mehta DM, Snow GB (1998) Malignant epithelial parotid gland tumours: analysis and results in 65 previously untreated patients. Br J Surg 85:1267–1272PubMedCrossRef Leverstein H, van der Wal JE, Tiwari RM, Tobi H, van der Waal I, Mehta DM, Snow GB (1998) Malignant epithelial parotid gland tumours: analysis and results in 65 previously untreated patients. Br J Surg 85:1267–1272PubMedCrossRef
8.
go back to reference Pedersen D, Overgaard J, Søgaard H, Elbrønd O, Overgaard M (1992) Malignant parotid tumors in 110 consecutive patients: treatment results and prognosis. Laryngoscope 102:1064–1069PubMedCrossRef Pedersen D, Overgaard J, Søgaard H, Elbrønd O, Overgaard M (1992) Malignant parotid tumors in 110 consecutive patients: treatment results and prognosis. Laryngoscope 102:1064–1069PubMedCrossRef
9.
go back to reference Zbären P, Schüpbach J, Nuyens M, Stauffer E, Greiner R, Häusler R (2003) Carcinoma of the parotid gland. Am J Sur 186:57–62CrossRef Zbären P, Schüpbach J, Nuyens M, Stauffer E, Greiner R, Häusler R (2003) Carcinoma of the parotid gland. Am J Sur 186:57–62CrossRef
10.
go back to reference Gallo O, Franchi A, Bottai GV, Fini-Storchi I, Tesi G, Boddi V (1997) Risk factors for distant metastases from carcinoma of the parotid gland. Cancer 80:844–851PubMedCrossRef Gallo O, Franchi A, Bottai GV, Fini-Storchi I, Tesi G, Boddi V (1997) Risk factors for distant metastases from carcinoma of the parotid gland. Cancer 80:844–851PubMedCrossRef
11.
go back to reference Lima RA, Tavares MR, Dias FL, Kligerman J, Nascimento MF, Barbosa MM, Cernea CR, Soares JR, Santos IC, Salviano S (2005) Clinical prognostic factors in malignant parotid gland tumors. Otolaryngol Head Neck Surg 133:702–708PubMedCrossRef Lima RA, Tavares MR, Dias FL, Kligerman J, Nascimento MF, Barbosa MM, Cernea CR, Soares JR, Santos IC, Salviano S (2005) Clinical prognostic factors in malignant parotid gland tumors. Otolaryngol Head Neck Surg 133:702–708PubMedCrossRef
12.
go back to reference Theriault C, Fitzpatrick PJ (1986) Malignant parotid tumors. Prognostic factors and optimum treatment. Am J Clin Oncol 9:510–516PubMedCrossRef Theriault C, Fitzpatrick PJ (1986) Malignant parotid tumors. Prognostic factors and optimum treatment. Am J Clin Oncol 9:510–516PubMedCrossRef
13.
go back to reference Carrillo JF, Vázquez R, Ramírez-Ortega MC, Cano A, Ochoa-Carrillo FJ, Oñate-Ocaña LF (2007) Multivariate prediction of the probability of recurrence in patients with carcinoma of the parotid gland. Cancer 15:2043–2051CrossRef Carrillo JF, Vázquez R, Ramírez-Ortega MC, Cano A, Ochoa-Carrillo FJ, Oñate-Ocaña LF (2007) Multivariate prediction of the probability of recurrence in patients with carcinoma of the parotid gland. Cancer 15:2043–2051CrossRef
14.
go back to reference Tullio A, Marchetti C, Sesenna E, Brusati R, Cocchi R, Eusebi V (2001) Treatment of carcinoma of the parotid gland: the results of a multicenter study. J Oral Maxillofac Surg 59:263–270PubMedCrossRef Tullio A, Marchetti C, Sesenna E, Brusati R, Cocchi R, Eusebi V (2001) Treatment of carcinoma of the parotid gland: the results of a multicenter study. J Oral Maxillofac Surg 59:263–270PubMedCrossRef
15.
go back to reference Pohar S, Gay H, Rosenbaum P, Klish D, Bogart J, Sagerman R, Hsu J, Kellman R (2005) Malignant parotid tumors: presentation, clinical/pathologic prognostic factors, and treatment outcomes. Int J Radiat Oncol Biol Phys 61:112–118PubMedCrossRef Pohar S, Gay H, Rosenbaum P, Klish D, Bogart J, Sagerman R, Hsu J, Kellman R (2005) Malignant parotid tumors: presentation, clinical/pathologic prognostic factors, and treatment outcomes. Int J Radiat Oncol Biol Phys 61:112–118PubMedCrossRef
16.
go back to reference Terhaard CH, van der Schroeff MP, van Schie K, Eerenstein SE, Lubsen H, Kaanders JH, Smeele LE, Burlage FR, van Den Ende PL, Baatenburg de Jong RJ (2005) The role of radiotherapy in the treatment of malignant salivary gland tumors. Int J Radiat Oncol Biol Phys 61:103–111PubMedCrossRef Terhaard CH, van der Schroeff MP, van Schie K, Eerenstein SE, Lubsen H, Kaanders JH, Smeele LE, Burlage FR, van Den Ende PL, Baatenburg de Jong RJ (2005) The role of radiotherapy in the treatment of malignant salivary gland tumors. Int J Radiat Oncol Biol Phys 61:103–111PubMedCrossRef
17.
go back to reference Bell RB, Dierks EJ, Homer L, Potter BE (2005) Management and outcome of patients with malignant salivary gland tumors. J Oral Maxillofac Surg 63:917–928PubMedCrossRef Bell RB, Dierks EJ, Homer L, Potter BE (2005) Management and outcome of patients with malignant salivary gland tumors. J Oral Maxillofac Surg 63:917–928PubMedCrossRef
18.
19.
go back to reference Witten J, Hybert F, Hansen HS (1990) Treatment of malignant tumors in the parotid glands. Cancer 65:2515–2520PubMedCrossRef Witten J, Hybert F, Hansen HS (1990) Treatment of malignant tumors in the parotid glands. Cancer 65:2515–2520PubMedCrossRef
20.
go back to reference Armstrong JG, Harrison LB, Thaler HT, Friedlander-Klar H, Fass DE, Zelefsky MJ, Shah JP, Strong EW, Spiro RH (1992) The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer 69:615–619PubMedCrossRef Armstrong JG, Harrison LB, Thaler HT, Friedlander-Klar H, Fass DE, Zelefsky MJ, Shah JP, Strong EW, Spiro RH (1992) The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer 69:615–619PubMedCrossRef
21.
go back to reference Harbo G, Bundgaard T, Pedersen D, Søgaard H, Overgaard J (2002) Prognostic indicators for malignant tumours of the parotid gland. Clin Otolaryngol Allied Sci 27:512–516PubMedCrossRef Harbo G, Bundgaard T, Pedersen D, Søgaard H, Overgaard J (2002) Prognostic indicators for malignant tumours of the parotid gland. Clin Otolaryngol Allied Sci 27:512–516PubMedCrossRef
22.
go back to reference Stennert E, Kisner D, Jungehuelsing M, Guntinas-Lichius O, Schröder U, Eckel HE, Klussmann JP (2003) High incidence of lymph node metastasis in major salivary gland cancer. Arch Otolaryngol Head Neck Surg 129:720–723PubMedCrossRef Stennert E, Kisner D, Jungehuelsing M, Guntinas-Lichius O, Schröder U, Eckel HE, Klussmann JP (2003) High incidence of lymph node metastasis in major salivary gland cancer. Arch Otolaryngol Head Neck Surg 129:720–723PubMedCrossRef
23.
go back to reference Terhaard C, Lubsen H, Tan B, Merkx T, van der Laan B, Baatenburg de Jong R, Manni H, Knegt P (2006) Facial nerve function in carcinoma of the parotid gland. Eur J Cancer 42:2744–50. Erratum in: Eur J Cancer, 2007, 43:1883 Terhaard C, Lubsen H, Tan B, Merkx T, van der Laan B, Baatenburg de Jong R, Manni H, Knegt P (2006) Facial nerve function in carcinoma of the parotid gland. Eur J Cancer 42:2744–50. Erratum in: Eur J Cancer, 2007, 43:1883
24.
go back to reference Poorten VV, Balm AJ, Hilgers FJ, Tan IB, Loftus-Coll BM, Keus RB, van Leeuwen FE, Hart AA (1999) The development of a prognostic score for patients with parotid carcinoma. Cancer 85:2057–2067 Poorten VV, Balm AJ, Hilgers FJ, Tan IB, Loftus-Coll BM, Keus RB, van Leeuwen FE, Hart AA (1999) The development of a prognostic score for patients with parotid carcinoma. Cancer 85:2057–2067
25.
go back to reference Poorten VV, Hart A, Vauterin T, Jeunen G, Schoenaers J, Hamoir M, Balm A, Stennert E, Guntinas-Lichius O, Delaere P (2009) Prognostic index for patients with parotid carcinoma: international external validation in a Belgian-German database. Cancer 115:540–550PubMedCrossRef Poorten VV, Hart A, Vauterin T, Jeunen G, Schoenaers J, Hamoir M, Balm A, Stennert E, Guntinas-Lichius O, Delaere P (2009) Prognostic index for patients with parotid carcinoma: international external validation in a Belgian-German database. Cancer 115:540–550PubMedCrossRef
Metadata
Title
Are all prognostic factors in parotid gland carcinoma well recognized?
Authors
Dominik Stodulski
Boguslaw Mikaszewski
Czeslaw Stankiewicz
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
European Archives of Oto-Rhino-Laryngology / Issue 3/2012
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-011-1716-6

Other articles of this Issue 3/2012

European Archives of Oto-Rhino-Laryngology 3/2012 Go to the issue